Panexcell Clinical Labs Pvt. Ltd is Premier Clinical Research Organization that serves both, the global pharmaceutical and biotech industry with the International standards, in compliance with ICH/GCP/GLP guidelines. We are headquartered at India and have business offices at United states, China and Australia. Our Indian site that is approved by all the major regulatory agencies across the world (USFDA / UKMHRA/ MOH Turkey/TGA Australia / MCC South Africa / HAS Singapore / MOH Malaysia / MOH Kazakhstan/HPRA Ireland). Panexcell has 60 bed clinical facility supported by 11 high end LC/MS-MS systems in the bioanalytical lab. We offer services in full-spectrum of clinical research covering complete life cycle of projects. Along with the capabilities of clinical operations in BA/BE and phase II-IV, we stand with a well-equipped bioanalytical lab armed with over 300 validated methods, strong biostatistics and medical writing capabilities, sound data management services, quality management and project management services. We have conducted more than 1100+ BE studies for different regions for various sponsors. We are working with many generic companies (80+ sponsors) operating worldwide for generic business. In addition to BA/BE experience, we have a group of highly skilled clinical research professionals to conduct Clinical Bio equivalence studies and phase II to IV clinical trials in India. Our core clinical capabilities includes Cardiology, Dermatology, Oncology, Ophthalmology, Orthopedic and Respiratory. The team has an experience of working with more than 300 clinical investigators across multiple research sites. Our services include medical writing, thorough project site including monitoring and data-management. We at Panexcell Clinical are committed to provide the best service in terms of clinical development and technical support to accelerate your drug development program.